Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
NCT ID: NCT06551038
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
240 participants
INTERVENTIONAL
2025-03-11
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this project is to test the effectiveness of a brief primary suicide prevention intervention for vulnerable adolescents, using a randomised controlled trial. Vulnerable adolescents include those 1) detained in juvenile detention centres, 2) at risk of dropping out of school, 3) undergoing treatment for psychiatric disorders, 4) belonging to a sexual or gender diversity, 5) affected by chronic conditions, or 6) with relational/familial problems. The main aim is to test the effectiveness of the intervention on a composite measure of suicide awareness, psychological distress and suicidal thoughts. The project will also explore other issues that present challenges for vulnerable populations: access to primary suicide prevention and non-response bias. The study will provide relevant results to address the current lack of high-quality evidence for primary suicide prevention in adolescents.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary suicide prevention intervention
The framework of the primary suicide prevention intervention is psychoeducation. The intervention lasts for 90 minutes and is conducted in groups of 5 to 15 (on average 10) participants. It provides general information on suicidal behaviors, information about facts and myths about suicide, identification of risk factors and warning signs of suicidal behaviors, and information on ways to seek for help and get support for themselves and others in the canton. The intervention includes a lecture, group discussions based on case examples, and a quiz on facts and myths about suicide. It is conducted by a trained staff member with the support of a psychologist trained in suicide prevention for children and adolescents. It follows a standardized format.
Primary suicide prevention intervention
Psychoeducation workshop
Art-based control intervention
The control intervention will be an art-based activity, a workshop on slam poetry. At the end of the study, participants will get a flyer containing information on suicide prevention with the participants of the control group. Therefore, they will have a low-threshold intervention.
Art-based control intervention
Slam poetry workshop
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Primary suicide prevention intervention
Psychoeducation workshop
Art-based control intervention
Slam poetry workshop
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 14 to 25 years old.
* Good knowledge of French.
* Accepting to sign the informed consent.
Exclusion Criteria
* Being enrolled in another suicide prevention intervention during the study period.
14 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stephanie Baggio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephanie Baggio
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphanie Baggio, Prof.
Role: PRINCIPAL_INVESTIGATOR
Institute of Primary Health Care (BIHAM), University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dialogai et Totem
Geneva, Canton of Geneva, Switzerland
Programme ForMe (anciennement SEMO) et dispositif ProPULSE
Plan-les-Ouates, Canton of Geneva, Switzerland
Centre de Détention et d'Observation La Clairière
Vernier, Canton of Geneva, Switzerland
Programme Intégration et Formation Professionnelle
Vernier, Canton of Geneva, Switzerland
Agnodice
Lausanne, Canton of Vaud, Switzerland
Vogay
Lausanne, Canton of Vaud, Switzerland
Centre Thérapeutique de Jour pour Adolescents
Lausanne, Canton of Vaud, Switzerland
Unité de Soins Psychiatriques Fermée pour Mineurs
Lausanne, Canton of Vaud, Switzerland
Établissement de Détention pour mineurs et jeunes adultes Les Léchaires
Palézieux, Canton of Vaud, Switzerland
Centre éducatif fermé de Pramont
Sierre, Valais, Switzerland
CAP Formations, Cité des Métiers
Geneva, , Switzerland
Unité de Liaison Ambulatoire et Hospitalière, Service de psychiatrie de l'enfant et de l'adolescent, HUG
Geneva, , Switzerland
Foyers de Gilly
Grand-Lancy, , Switzerland
Foyer de Chailly
Lausanne, , Switzerland
Ren'Fort
Lausanne, , Switzerland
Foyer La Pommeraie
Lonay, , Switzerland
Service des Parcours Individualisé
Onex, , Switzerland
Le Repuis
Petit Lancy, , Switzerland
Astural, Parcours A2mains
Thônex, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nadjeda Lambert
Role: primary
Nadejda Lambert
Role: primary
Patrick Heller, MD
Role: primary
Nadejda Lambert
Role: primary
Nadejda Lambert
Role: primary
Nadejda Lambert
Role: primary
Sébastien Urben, Dr.
Role: primary
Sébastien Urben, Dr.
Role: primary
Patrick Heller, MD
Role: primary
Patrick Heller, MD
Role: primary
Stéphanie Baggio, PhD
Role: backup
Nadejda Lambert
Role: primary
Santiago Peregalli
Role: primary
Patrick Heller, MD
Role: primary
Patrick Heller, MD
Role: primary
Nadejda Lambert
Role: primary
Patrick Heller, MD
Role: primary
Nadejda Lambert
Role: primary
Nadejda Lambert
Role: primary
Nadejda Lambert
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Baggio S, Bailey E, Edan A, Heller P, Kapp C, Lambert N, Michaud L, Mundt AP, Nsingi N, Perez S, Peregalli S, Piguet C, Piotrowski C, Prutyanova Y, Rumley M, Sapin M, Urben S, Iglesias K. Evaluating primary suicide prevention in adolescents with risk factors (ESPAIR): study protocol for a cluster-randomized controlled trial. Trials. 2025 Nov 24;26(1):537. doi: 10.1186/s13063-025-09266-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-01208
Identifier Type: -
Identifier Source: org_study_id